Clinical Trial Update: Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the neoadjuvant chemotherapy-targeted therapy combination in breast cancer, with pathological response rate as an endpoint, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy-Targeted Therapy

Snippet

Sponsor: Centre Jean Perrin | Conditions: Pathological Response Rate | Phase 2 | Status: COMPLETED